Working groups
Rebecca Winter has over 15 years of experience in public health research. Primarily, she has worked on studies relating to risk behaviours and risk groups relating to communicable disease transmission, with a particular interest in drug user and justice-involved populations.
Rebecca completed her doctoral studies on injecting drug-related harms among prisoners and ex-prisoners in 2016.
The hepatitis C virus impacts approximately 200,000 Australians, according to the National Centre in HIV Epidemiology and Clinical Research (NCHECR) in 2010. Presently, there is no vaccine available to prevent transmission of the virus. In New South Wales alone, there were 3,950 new diagnoses of hepatitis C infection in 2009, as reported by the NCHECR.
Technical review of hepatitis C health promotion resources.International Journal of Drug Policy
S. Griffin, Shelley Walker, Sophia Schroeder, Margaret Hellard, Mark Stoové, Rebecca Winter
The Medical Journal of Australia
Rebecca Winter, Farah Houdroge, Samantha Colledge‐Frisby, Mark Stoové, Nick Scott, Farah Houdroge, Samantha Colledge‐Frisby, Rebecca Winter, Mark Stoové, Nick Scott
The Medical Journal of Australia
Rebecca Winter, Farah Houdroge, Samantha Colledge‐Frisby, Mark Stoové, Nick Scott, Farah Houdroge, Samantha Colledge‐Frisby, Rebecca Winter, Mark Stoové, Nick Scott
This project addresses critical knowledge gaps in Australian and global efforts to eliminate hepatitis C as a public health threat by 2030.
A partnership aimed at increasing hepatitis C treatment uptake among people who inject drugs (PWID) using nurse-led models of care in community and prison settings.
This study provided evidence on whether a supervised drug consumption room (or rooms) is suited to the ACT context.